• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对培养阴性肺结核的超短程化疗——取得了有限的成功。

Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.

作者信息

Cowie R L, Langton M E, Escreet B C

出版信息

S Afr Med J. 1985 Dec 7;68(12):879-80.

PMID:4071345
Abstract

A group of 250 patients with new or enlarging apical lung lesions which were thought to be tuberculous, and who had positive tuberculin tests but negative sputum smears and cultures for Mycobacterium tuberculosis, were treated with an ultrashort (3-month), 4-drug (rifampicin, isoniazid, pyrazinamide and ethambutol) regimen. One patient developed bacteriologically positive pulmonary tuberculosis (PTB) during the treatment period and 35 others (14%) developed bacteriologically positive PTB after completing the drug regimen.

摘要

一组250例患者,其肺部新出现或增大的尖部病变被认为是结核性的,结核菌素试验呈阳性,但痰涂片和结核分枝杆菌培养均为阴性,接受了超短程(3个月)四联(利福平、异烟肼、吡嗪酰胺和乙胺丁醇)治疗方案。1例患者在治疗期间出现细菌学阳性的肺结核(PTB),另外35例(14%)在完成治疗方案后出现细菌学阳性的PTB。

相似文献

1
Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.针对培养阴性肺结核的超短程化疗——取得了有限的成功。
S Afr Med J. 1985 Dec 7;68(12):879-80.
2
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].[使用异烟肼、利福平与吡嗪酰胺固定组合进行肺结核的短期治疗。2年后的结果]
Schweiz Med Wochenschr. 1989 Mar 11;119(10):299-305.
3
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].含吡嗪酰胺的6个月方案治疗初治肺结核患者的疗效及问题
Kekkaku. 2001 Jan;76(1):33-43.
4
Present status of chemotherapy for tuberculosis.结核病化疗的现状
Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S347-52. doi: 10.1093/clinids/11.supplement_2.s347.
5
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.耐多药肺结核12个月治疗方案的结果
Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9.
6
Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.快速口服异烟肼和吡嗪酰胺诱导耐受并控制乙胺丁醇给药:临床病例
Allergol Immunopathol (Madr). 2009 Nov-Dec;37(6):336-8. doi: 10.1016/j.aller.2009.05.006.
7
[Fever and thin-walled cavitary lung lesions].[发热与薄壁肺空洞病变]
Enferm Infecc Microbiol Clin. 2009 Jun;27(6):363-4. doi: 10.1016/j.eimc.2008.07.010. Epub 2009 May 6.
8
[Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].异烟肼、利福平、乙胺丁醇方案与异烟肼、利福平、吡嗪酰胺方案用于肺结核初治化疗的对照试验(作者译)
Kekkaku. 1980 Jan;55(1):7-13.
9
Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.阿尔及利亚撒哈拉地区治疗肺结核的6个月疗程与12个月疗程对比的对照临床试验。阿尔及利亚工作组/英国医学研究理事会合作研究。
Am Rev Respir Dis. 1984 Jun;129(6):921-8. doi: 10.1164/arrd.1984.129.6.921.
10
[Antitubercular chemotherapy].[抗结核化疗]
Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104.

引用本文的文献

1
Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.影像学活动性、痰培养阴性肺结核的治疗:系统评价和荟萃分析。
PLoS One. 2023 Nov 16;18(11):e0293535. doi: 10.1371/journal.pone.0293535. eCollection 2023.